Trial Profile
A 3-month, randomized, double-blinded, active-controlled, parallel-group study to evaluate the safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Brinzolamide/timolol (Primary) ; Dorzolamide/timolol
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- 04 Nov 2015 New trial record